262
30. Melzer D, Rice NE, Lewis C, Henley WE, Galloway TS. Association of urinary bisphenol a concentration with heart disease: evidence from NHANES 2003/06. PLoS One. 2010;5(1):e8673.
Epub 2010/01/20. eng.
31. Shankar A, Teppala S, Sabanayagam C. Bisphenol A and peripheral arterial disease: results
from the NHANES. Environ Health Perspect. 2012;120(9):1297–300. Epub 2012/05/31. eng.
32. Gao X, Liang Q, Chen Y, Wang HS. Molecular mechanisms underlying the rapid arrhythmogenic action of bisphenol A in female rat hearts. Endocrinology. 2013;154(12):4607–17. Epub
2013/10/22. eng.
33. Bers DM. Cardiac excitation-contraction coupling. Nature. 2002;415(6868):198–205. Epub
2002/01/24. eng.
34. Jayashree S, Indumathi D, Akilavalli N, Sathish S, Selvaraj J, Balasubramanian K. Effect of
Bisphenol-A on insulin signal transduction and glucose oxidation in liver of adult male albino
rat. Environ Toxicol Pharmacol. 2013;35(2):300–10. Epub 2013/02/05. eng.
35. Huc L, Lemarié A, Guéraud F, Héliès-Toussaint C. Low concentrations of bisphenol A induce
lipid accumulation mediated by the production of reactive oxygen species in the mitochondria
of HepG2 cells. Toxicol in Vitro. 2012;26(5):709–17.
36. Moon MK, Kim MJ, Jung IK, Koo YD, Ann HY, Lee KJ, et al. Bisphenol A impairs mitochondrial function in the liver at doses below the no observed adverse effect level. J Korean Med
Sci. 2012;27(6):644–52. Epub 2012/06/13. eng.
37. Rogers JA, Metz L, Yong VW. Review: Endocrine disrupting chemicals and immune responses:
a focus on bisphenol-A and its potential mechanisms. Mol Immunol. 2013;53(4):421–30.
Epub 2012/11/06. eng.
38. Youn JY, Park HY, Lee JW, Jung IO, Choi KH, Kim K, et al. Evaluation of the immune
response following exposure of mice to bisphenol A: induction of Th1 cytokine and prolactin by BPA exposure in the mouse spleen cells. Arch Pharm Res. 2002;25(6):946–53. Epub
2003/01/04. eng.
39. Wetherill YB, Akingbemi BT, Kanno J, McLachlan JA, Nadal A, Sonnenschein C, et al. In
vitro molecular mechanisms of bisphenol A action. Reprod Toxicol. 2007;24(2):178–98. Epub
2007/07/14. eng.
40. Goto M, Takano-Ishikawa Y, Ono H, Yoshida M, Yamaki K, Shinmoto H. Orally administered bisphenol A disturbed antigen specific immunoresponses in the naive condition. Biosci
Biotechnol Biochem. 2007;71(9):2136–43. Epub 2007/09/11. eng.
41. Roy A, Bauer SM, Lawrence BP. Developmental exposure to bisphenol A modulates innate but
not adaptive immune responses to influenza A virus infection. PLoS One. 2012;7(6):e38448.
Epub 2012/06/08. eng.
42. Clayton EM, Todd M, Dowd JB, Aiello AE. The impact of bisphenol A and triclosan on
immune parameters in the U.S. population, NHANES 2003-2006. Environ Health Perspect.
2011;119(3):390–6. Epub 2010/11/11. eng.
43. Audebert M, Dolo L, Perdu E, Cravedi JP, Zalko D. Use of the gammaH2AX assay for
assessing the genotoxicity of bisphenol A and bisphenol F in human cell lines. Arch Toxicol.
2011;85(11):1463–73. Epub 2011/06/10. eng.
44. Atkinson A, Roy D. In vivo DNA adduct formation by bisphenol A. Environ Mol Mutagen.
1995;26(1):60–6. Epub 1995/01/01. eng.
45. Kolsek K, Mavri J, Sollner DM. Reactivity of bisphenol A-3,4-quinone with DNA. A quantum
chemical study. Toxicol in Vitro. 2012;26(1):102–6. Epub 2011/11/29. eng.
46. Donato J Jr, Cravo RM, Frazao R, Elias CF. Hypothalamic sites of leptin action linking metabolism and reproduction. Neuroendocrinology. 2011;93(1):9–18. Epub 2010/11/26. eng.
47. Ben-Jonathan N, Hugo ER, Brandebourg TD. Effects of bisphenol A on adipokine release
from human adipose tissue: implications for the metabolic syndrome. Mol Cell Endocrinol.
2009;304(1-2):49–54. Epub 2009/05/13. eng.
48. Somm E, Schwitzgebel VM, Vauthay DM, Camm EJ, Chen CY, Giacobino JP, et al. Prenatal
nicotine exposure alters early pancreatic islet and adipose tissue development with consequences on the control of body weight and glucose metabolism later in life. Endocrinology.
2008;149(12):6289–99. Epub 2008/08/09. eng.
K. Irshad et al.
30. Melzer D, Rice NE, Lewis C, Henley WE, Galloway TS. Association of urinary bisphenol a concentration with heart disease: evidence from NHANES 2003/06. PLoS One. 2010;5(1):e8673.
Epub 2010/01/20. eng.
31. Shankar A, Teppala S, Sabanayagam C. Bisphenol A and peripheral arterial disease: results
from the NHANES. Environ Health Perspect. 2012;120(9):1297–300. Epub 2012/05/31. eng.
32. Gao X, Liang Q, Chen Y, Wang HS. Molecular mechanisms underlying the rapid arrhythmogenic action of bisphenol A in female rat hearts. Endocrinology. 2013;154(12):4607–17. Epub
2013/10/22. eng.
33. Bers DM. Cardiac excitation-contraction coupling. Nature. 2002;415(6868):198–205. Epub
2002/01/24. eng.
34. Jayashree S, Indumathi D, Akilavalli N, Sathish S, Selvaraj J, Balasubramanian K. Effect of
Bisphenol-A on insulin signal transduction and glucose oxidation in liver of adult male albino
rat. Environ Toxicol Pharmacol. 2013;35(2):300–10. Epub 2013/02/05. eng.
35. Huc L, Lemarié A, Guéraud F, Héliès-Toussaint C. Low concentrations of bisphenol A induce
lipid accumulation mediated by the production of reactive oxygen species in the mitochondria
of HepG2 cells. Toxicol in Vitro. 2012;26(5):709–17.
36. Moon MK, Kim MJ, Jung IK, Koo YD, Ann HY, Lee KJ, et al. Bisphenol A impairs mitochondrial function in the liver at doses below the no observed adverse effect level. J Korean Med
Sci. 2012;27(6):644–52. Epub 2012/06/13. eng.
37. Rogers JA, Metz L, Yong VW. Review: Endocrine disrupting chemicals and immune responses:
a focus on bisphenol-A and its potential mechanisms. Mol Immunol. 2013;53(4):421–30.
Epub 2012/11/06. eng.
38. Youn JY, Park HY, Lee JW, Jung IO, Choi KH, Kim K, et al. Evaluation of the immune
response following exposure of mice to bisphenol A: induction of Th1 cytokine and prolactin by BPA exposure in the mouse spleen cells. Arch Pharm Res. 2002;25(6):946–53. Epub
2003/01/04. eng.
39. Wetherill YB, Akingbemi BT, Kanno J, McLachlan JA, Nadal A, Sonnenschein C, et al. In
vitro molecular mechanisms of bisphenol A action. Reprod Toxicol. 2007;24(2):178–98. Epub
2007/07/14. eng.
40. Goto M, Takano-Ishikawa Y, Ono H, Yoshida M, Yamaki K, Shinmoto H. Orally administered bisphenol A disturbed antigen specific immunoresponses in the naive condition. Biosci
Biotechnol Biochem. 2007;71(9):2136–43. Epub 2007/09/11. eng.
41. Roy A, Bauer SM, Lawrence BP. Developmental exposure to bisphenol A modulates innate but
not adaptive immune responses to influenza A virus infection. PLoS One. 2012;7(6):e38448.
Epub 2012/06/08. eng.
42. Clayton EM, Todd M, Dowd JB, Aiello AE. The impact of bisphenol A and triclosan on
immune parameters in the U.S. population, NHANES 2003-2006. Environ Health Perspect.
2011;119(3):390–6. Epub 2010/11/11. eng.
43. Audebert M, Dolo L, Perdu E, Cravedi JP, Zalko D. Use of the gammaH2AX assay for
assessing the genotoxicity of bisphenol A and bisphenol F in human cell lines. Arch Toxicol.
2011;85(11):1463–73. Epub 2011/06/10. eng.
44. Atkinson A, Roy D. In vivo DNA adduct formation by bisphenol A. Environ Mol Mutagen.
1995;26(1):60–6. Epub 1995/01/01. eng.
45. Kolsek K, Mavri J, Sollner DM. Reactivity of bisphenol A-3,4-quinone with DNA. A quantum
chemical study. Toxicol in Vitro. 2012;26(1):102–6. Epub 2011/11/29. eng.
46. Donato J Jr, Cravo RM, Frazao R, Elias CF. Hypothalamic sites of leptin action linking metabolism and reproduction. Neuroendocrinology. 2011;93(1):9–18. Epub 2010/11/26. eng.
47. Ben-Jonathan N, Hugo ER, Brandebourg TD. Effects of bisphenol A on adipokine release
from human adipose tissue: implications for the metabolic syndrome. Mol Cell Endocrinol.
2009;304(1-2):49–54. Epub 2009/05/13. eng.
48. Somm E, Schwitzgebel VM, Vauthay DM, Camm EJ, Chen CY, Giacobino JP, et al. Prenatal
nicotine exposure alters early pancreatic islet and adipose tissue development with consequences on the control of body weight and glucose metabolism later in life. Endocrinology.
2008;149(12):6289–99. Epub 2008/08/09. eng.
K. Irshad et al.